A digital support package after hospital rehabilitation for people with heart disease
Tests a digital support package after cardiac rehabilitation in adults with heart disease.
Plain-language title generated from the registry record
Registry title: Transcultural Digital Solutions in Phase III Cardiac Rehabilitation
Key facts
- Where
- Castellanza, Lumezzane, and Milan, ItalySee the 3 sites
Where in Italy
- Carlo Cattaneo - LIUC UniversityCastellanza, ItalyNot yet recruiting
- Istituti Clinici Scientifici Maugeri SpA - Società Benefit, IRCCS, LumezzaneLumezzane, ItalyTaking people
- IRCCS DongnocchiMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione Don Carlo Gnocchi ETS
- Trial code
- NCT07252856
- Record updated
- 30 June 2026
- Original description
Multicenter Prospective Controlled Randomized Trial, open-label, in patients with atherosclerotic cardiovascular disease (ASCVD) (acute coronary syndrome or chronic coronary syndrome and ischemic heart failure) and an approved indication for cardiac rehabilitation (CR). Patients completing phase II CR will be randomized 1:1 to usual Phase-III care (standard care) versus standard care plus the Digitally-Enhanced Extended PrEvention \& Rehabilitation (DEEPER) package (intervention). Primary outcome is 6-month change in composite Life's Crucial 9 (LC9) (LE8 + PHQ-9).Read full original descriptionShow less
CrOss-cultural Model for Postdischarge Assistance and Sustainable Digital Solutions in Phase III Cardiac Rehabilitation: a Randomized Controlled Trial
Multicenter Prospective Controlled Randomized Trial, open-label, in patients with atherosclerotic cardiovascular disease (ASCVD) (acute coronary syndrome or chronic coronary syndrome and ischemic heart failure) and an approved indication for cardiac rehabilitation (CR). Patients completing phase II CR will be randomized 1:1 to usual Phase-III care (standard care) versus standard care plus the Digitally-Enhanced Extended PrEvention \& Rehabilitation (DEEPER) package (intervention). Primary outcome is 6-month change in composite Life's Crucial 9 (LC9) (LE8 + PHQ-9).
Inclusion: Age ≥ 18, men and women; patients with atherosclerotic cardiovascular disease (ASCVD) (acute coronary syndrome or chronic coronary syndrome and ischemic heart failure); patients who completed phase II CR and are therefore eligible for CR phase III (maintenance).
Exclusion: Unable to sign the informed consent; unable or unwilling to use digital devices due to mental/cognitive issues or without a support person helping them to access the respective technical devices; pregnant, lactating or women planning pregnancy during the course of the trial.